Abich Financial Wealth Management »

Iovance Biotherapeutics shares owned by Abich Financial Wealth Management

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Abich Financial Wealth Management from 13F filings

Historical chart of Abich Financial Wealth Management investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Abich Financial Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Abich Financial Wealth Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $8.2k 868 9.39
2024-06-30 $1.8k 220 8.02
2024-03-31 $266 18 14.83

More positions owned by Abich Financial Wealth Management

Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Spdr Ser Tr Portfolio S&p400 (SPMD)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Spdr Ser Tr Portfolio S&p600 (SPSM)
Franklin Templeton Etf Tr Ftse Japan Etf (FLJP)
Raytheon Technologies Corp (RTX)
Exxon Mobil Corporation (XOM)
Cisco Systems (CSCO)
Wells Fargo & Company (WFC)
Comcast Corp Cl A (CMCSA)
Merck & Co (MRK)

View all positions for Abich Financial Wealth Management

Top funds holding Iovance Biotherapeutics

Vanguard Group
Perceptive Advisors
MHR Fund Management
BlackRock
State Street Corporation
Soleus Capital Management
Hood River Capital Management
T. Rowe Price Investment Management
Geode Capital Management
Balyasny Asset Management
Artisan Partners Limited Partnership
Long Focus Capital Management
Goldman Sachs Group
venBio Select Advisor
Principal Financial Group

View all funds holding Iovance Biotherapeutics